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more penicillin-susceptible and less multi-drug resistant Sp isolates in PCV immunized children.
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Streptococcus pneumoniae (Sp), Haemophilus influenzae
(Hi), and Moraxella catarrhalis (Mc) are the most prevalent
bacteria isolated from children with acute otitis mediaof Otolaryngology-Head and
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Society of Microbiology. Published(AOM).1 To prevent invasive pneumococcal diseases,
pneumococcal conjugate vaccines (PCVs) have been intro-
duced worldwide. To some extent, these vaccines have also
been shown to reduce AOM burden.2 The decrease in AOM
incidence after 7-valent pneumococcal conjugate vaccine
(PCV7) introduction was blunted by the emergence of
nonvaccine serotypes of Sp, which eventually led to the
introduction of the broader spectrum 13-valent vaccine.
Various national guidelines recommending antibiotic
treatment for AOM are continuously updated, based on
bacterial data and antibiotic resistance patterns. The
American Academy of Pediatrics and the Israeli Task Forcenization with pneumococcal conjugated vaccines on Streptococcus
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by Elsevier Taiwan LLC. All rights reserved.
2 T. Marom et al.
+ MODELguidelines for AOM diagnosis and management recommend
amoxicillin as the first-line treatment.3,4 Despite stringent
criteria for AOM treatment and efforts to restrain unjustified
antibiotic use, prescription rates are still high nationwide (>
85%).5 In recent years, Sp pathogenicity in children with AOM
has been extensively studied. Reported resistance tests to
antibiotic agents from different countries are conflicting.6e8
Knowledge of Sp resistance patterns to antibiotics is essen-
tial when choosing appropriate treatment for AOM.
In Israel, PCV7 and 13-valent pneumococcal conjugate
vaccine (PCV13) were implemented in a relatively short
period in the National Immunization Program (NIP) in 2009
and 2010, respectively. We sought to study the impact of
PCVs on pneumococcal isolates obtained from severe forms
of AOM episodes, by analyzing the changes in Sp resistance
patterns in the pre- and postPCVs era.
Methods
Study design and population
The Institutional Review Board and the Health Information
Transfer Committee of the Israeli Ministry of Health
approved this study. The study design has been previously
described in detail.9 In brief, we retrospectively identified
children < 6 years of age with middle ear fluid (MEF) cul-
tures during 2008e2013 which were obtained from “severe”
AOM episodes. “Severe” AOM episodes were defined as
those that either required tympanocentesis, due to lack of
clinical improvement despite  48 hours of adequate
antibiotic therapy, or if there were any signs of AOM-
related complications (mastoiditis and/or subperiosteal
abscess and/or sigmoid sinus thrombosis, facial nerve palsy,
meningitis, intracranial abscess), or if children presented
with spontaneous otorrhea, due to an increased middle ear
pressure which caused tympanic membrane perforation.
For each eligible child, we retrieved clinical and demo-
graphical data from his/her medical records. Concurrently,
PCV immunization data were retrieved from the NIP records
(permission granted by the Ministry of Health Ethical
Committee). Each child was categorized according to his/
her PCV status at AOM presentation as “unimmunized”, if
he had not received any dose of PCV, “PCV7-” or “PCV13-
immunized”, if he had received  1 dose(s) of PCV7 or
PCV13, respectively. If a child had received PCV7 and
PCV13 dose(s), the child was considered as “PCV13-
immunized”, due to broader coverage of PCV13.10
Middle ear fluid culture collection and processing
Tympanocentesis was performed in the anterioreinferior
quarter of the tympanic membrane, in the office with local
analgesia, or in the operating room under general anes-
thesia. Middle ear fluid (MEF) specimens were collected
using a designated sterile flocked swab (Copan Italia,
Brescia, Italy) after cleaning of the external auditory canal
with an antiseptic solution, or by sampling of otorrhea
through an existing tympanic membrane perforation. Sp,
Hi, and Mc were considered as true otopathogens. In
bilateral AOM cases, MEF specimens were obtained from
both ears, but were considered as one sample.Please cite this article in press as: Marom T, et al., The effect of immu
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ratory and processed there within 24e48 hours after sam-
pling. The specimens were plated on blood agar medium
with 5% sheep blood and chocolate agar. The plates were
incubated at 37C with 5% CO2 for 24e48 hours. Sp was
identified using morphological characteristics, a-hemolysis,
and optochin susceptibility. All other MEF culture results
(e.g., Streptococcus viridians, Streptococcus pyogenes
group A, or external ear canal saprophytes) were excluded
because they were not regarded as true “classic” oto-
pathogens. Penicillin and amoxicillin susceptibility was
examined by the E-test (BioMerieux, Paris, France); the
remaining antimicrobials were tested by disc diffusion
method (Bio-Rad, Hercules, California, USA). Zone diam-
eter breakpoint and minimal inhibitory concentration (MIC)
category interpretations were based on updated standards
(European Committee on Antimicrobial Susceptibility
Testing, 2013). For the purpose of this study, we focused
only on Sp, which is still considered as the major AOM
pathogen. Antibiotic susceptibility was determined by Vitek
2. Penicillin-susceptible Sp (PSSP) was defined if MIC was <
0.06 mg/L. Penicillin nonsusceptible Sp (PNSP) was
considered if MIC to penicillin was > 0.06 mg/L, and
included intermediate-susceptible, if MIC was 0.06e2 mg/
L, and resistant, if MIC was  2 mg/L. Multi-drug resistance
(MDR) was defined as nonsusceptibility to b-lactam and
resistance to two other antibiotic families, such as cefur-
oxime, ceftriaxone, erythromycin, and trimethoprim/sul-
famethoxazole (TMP/SMX).
Statistical analysis
The unit for analysis was AOM episode with Sp positive MEF
culture. Categorical variables are described as n (%) and,
we used Chi-square test or Fisher’s exact test, as appro-
priate. Statistical significance was defined as p  0.05 (2-
sided). All analyses were performed using SPSS, version
17.0 (IBM Inc., Chicago, Illinois, USA).
Results
Demographics
A total of 279 children who met the eligibility criteria
contributed 295 “severe” AOM episodes. Of those, 106
(36%) MEF cultures from 103 children tested positive for any
of the three otopathogens (3 children contributed 2 MEF
cultures each. As those MEF cultures were derived from
distinct severe AOM episodes, we referred those episodes
as independent): Sp, in 59 episodes; Hi, in 39 episodes; Mc,
in two episodes; and mixed growth, in six episodes.
Therefore, our study population consisted of 65 episodes in
which Sp was isolated: as a single bacterium in 59 (91%),
and in six (9%) as a mixed growth, with nontypeable Hi.
There were more boys (39, 60%), and most of Sp positive
MEF cultures were from children < 2 years old (52, 80%).
Prior antibiotic therapy was given in 23 (35%) children [the
most common antibiotic therapy was amoxicillin, in 14
(61%) episodes]. In 2008, all children were PCV unimmu-
nized, whereas w90% were PCV-immunized in 2013. The
percentage of Sp positive MEF cultures from the sum ofnization with pneumococcal conjugated vaccines on Streptococcus
crobiology, Immunology and Infection (2015), http://dx.doi.org/
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29), 47% (7/15), 68% (13/19), 62% (13/21), 44% (4/9), 38%
(5/13), respectively. Thirty-one (48%) of the pneumococci
were cultured from unimmunized children (23, 6, 1, 0, 0,
and 1 in 2008e2013, respectively), 21 (32%) from PCV7-
immunized children (0, 1, 12, 6, 1, and 1 in 2008e2013,
respectively), and 13 (20%) from PCV13-immunized children
(0, 0, 0, 7, 3, and 3 in 2008e2013, respectively).
Resistance patterns
The overall PNSP proportion was 51% (33/65; 31% interme-
diate, 20% resistant) and was significantly associated with
PCV-status (p Z 0.006). Figure 1 presents PSSP/PNSP
partition of isolated Sp in MEF cultures according to PCV
status at AOM presentation. PNSP proportion in unimmu-
nized children was higher than in PCV immunized children,
68% (21/31) versus 35% (12/34; p Z 0.009). The MDR
prevalence of pneumococcal strains was 11% (7/65). MDR
prevalence in unimmunized children was 23% (7/31)
compared with 0% (0/34) in immunized children
(p Z 0.004). Concomitant resistance to TMP/SMX and
erythromycin were recorded in 17 (26%) and 15 (23%) cul-
tures, respectively. Sp resistance to erythromycin and TMP/
SMX substantially decreased: 40% (12/30) versus 9% (3/35)
and 57% (17/30) versus 0% (0/35), 2008e2009 versus
2010e2013,; p Z 0.003 and p < 0.0001, respectively.
Discussion
We retrospectively analyzed Sp resistance patterns in se-
vere AOM episodes in young children who had MEF culturesFigure 1. PNSP/PSSP partition in Sp positive MEF cultures from “s
rate was 51% (31% intermediate, 20% resistant) and demonstrated
Unimmunized children had higher PNSP rate than PCV7 immunized c
children (pZ 0.002). AOMZ acute otitis media; MEFZ middle ear
pneumococcal conjugate vaccine; PCV13 Z 13-valent pneumococca
coccus pneumoniae; PSSP Z Penicillin susceptible Streptococcus pn
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role of Sp in positive MEF cultures. In our study population,
children presented with severe AOM, despite moderate
preadmission antibiotic treatment utilization. In addition,
they had low PNSP/PSSP rates and MDR phenotypes.
Possible explanations include low compliance (inadequate
or faulty intake of antibiotic treatment), insufficient anti-
biotic dosage (i.e., amoxicillin at 40 mg/kg/d), shorter than
recommended duration of therapy (< 7e10 days) or
administration of inappropriate antibiotics. In PCV immu-
nized children, there was an increased susceptibility to
other common antibiotic treatments (TMP/SMX, erythro-
mycin and cephalosporins), which can be explained by the
different antibiotic susceptibilities to antibiotic agents of
current Sp strains.
In our study, approximately one third of children
received antibiotics for AOM before their admission; most
of them were prescribed amoxicillin. Selection of b-lactams
as the first line antibiotics in our study population could be
considered appropriate. Our results support current
recommendation for amoxicillin, because the majority of
isolated pneumococci were PSSP.
Our strengths include: (1) analysis of Sp isolated directly
from MEF, and not from the nasopharynx, which is regarded
by many authors as a proxy to the middle ear; (2) demon-
stration of 1:1 correlation between PCV status and Sp
resistance patterns; and (3) validation and affirmation of the
current guidelines recommendation to use amoxicillin for
AOM treatment. Limitations include: (1) lack of serotyping
(therefore, we could not observe the changes in vaccine and
nonvaccine serotypes over time); (2) no multilocus sequence
typing analysis of isolates with MDR phenotype; and (3) bias
of study population selection from the “advanced” spectrumevere” AOM episodes, according to PCV status. The overall PNSP
statistically significant association on PCV-status (p Z 0.006).
hildren (pZ 0.15), and higher PNSP rate than PCV13 immunized
fluid; PCVZ pneumococcal conjugate vaccine; PCV7Z 7-valent
l conjugate vaccine; PNSP Z Penicillin nonsusceptible Strepto-
eumoniae; Sp Z Streptococcus pneumoniae.
nization with pneumococcal conjugated vaccines on Streptococcus
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cated forms of AOM. However, we believe that our results
are an important indirect observation on the circulating Sp
serotypes in the postPCV era. Furthermore, uncomplicated
AOM cases treated as outpatients, and are usually respon-
sive to antibiotic therapy; therefore, MEF cultures are not
obtained from these patients.
In conclusion, we demonstrated a high rate of antibiotic
susceptibility of Sp in our study population, despite inter-
mediate use of antibiotics. Undoubtedly, ongoing surveil-
lance of Sp antimicrobial susceptibility, MDR phenotype,
and serotype frequency will be critical in order to assess
the impact of the broader coverage of PCV13.
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